| Absorption |
| Blood-Brain Barrier | BBB+ | 0.5843 |
| Human Intestinal Absorption | HIA+ | 0.9871 |
| Caco-2 Permeability | Caco2+ | 0.7568 |
| P-glycoprotein Substrate | Non-substrate | 0.7276 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9849 |
| Non-inhibitor | 0.9917 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9113 |
| Distribution |
| Subcellular localization | Lysosome | 0.7779 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8077 |
| CYP450 2D6 Substrate | Non-substrate | 0.8418 |
| CYP450 3A4 Substrate | Non-substrate | 0.8063 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9261 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9096 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9446 |
| Non-inhibitor | 0.9370 |
| AMES Toxicity | Non AMES toxic | 0.9132 |
| Carcinogens | Non-carcinogens | 0.6929 |
| Fish Toxicity | Low FHMT | 0.6482 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7733 |
| Honey Bee Toxicity | Low HBT | 0.5715 |
| Biodegradation | Not ready biodegradable | 0.6917 |
| Acute Oral Toxicity | III | 0.8360 |
| Carcinogenicity (Three-class) | Non-required | 0.6955 |